AMENDMENT NO. 19 TO SCHEDULE 13D
This Amendment No. 19 to Schedule 13D (this Nineteenth Amendment) amends and supplements the Schedule 13D originally filed on
April 17, 2008, as amended by Amendment No. 1 on June 25, 2008, Amendment No. 2 on August 28, 2008, Amendment No. 3 on September 29, 2008, Amendment No. 4 on December 30, 2008, Amendment No. 5 on
July 2, 2009, Amendment No. 6 on December 3, 2009, Amendment No. 7 on September 13, 2010, Amendment No. 8 on May 17, 2011, Amendment No. 9 on March 23, 2012, Amendment No. 10 on January 10,
2014, Amendment No. 11 on January 14, 2015, Amendment No. 12 on May 5, 2015, Amendment No. 13 on August 28, 2015, Amendment No. 14 on April 13, 2016, Amendment No. 15 on July 12, 2016, Amendment
No. 16 on December 1, 2016, Amendment No. 17 on April 20, 2017 and Amendment No. 18 on December 6, 2017 (collectively, the Schedule 13D). Unless otherwise indicated, all capitalized terms used but not
defined herein shall have the same meaning ascribed to them in the Schedule 13D.
This Nineteenth Amendment is being filed to make updates and
amendments to the Schedule 13D as follows:
Item 1.
|
Security and Issuer
|
There are no changes to the Item 1 information previously filed.
Item 2.
|
Identity and Background
|
There are no changes to the Item 2 information previously filed.
Item 3.
|
Source and Amount of Funds or Other Consideration
|
In addition to the Item 3 information previously filed, Mr. Mitchell and his affiliated entities are in discussions with third
parties regarding sources of funds to acquire the Issuers equity that are not currently owned by Mr. Mitchell and his affiliated entities. Such sources of funds will likely result in Mr. Mitchell and his affiliated entities
partnering with one or more parties to collectively raise sufficient funds to acquire 100% of the Issuers equity. Whether any funds will be raised as debt from banks or other sources is not certain.
Item 4.
|
Purpose of Transaction
|
Item 4 is hereby amended and supplemented by adding the following paragraphs thereto:
The Reporting Persons intend to pursue the acquisition of 100% of the Issuers equity. The Reporting Persons expect to commence
non-binding
negotiations with the Issuer to consummate such acquisition and the Reporting Persons may terminate any such discussions at any time in their sole discretion. There can be no assurance that such
acquisition will be agreed to or consummated. The Reporting Persons do not undertake to amend this Schedule 13D to reflect any discussions with the Issuer regarding the proposal made until such time, if any, as a definitive agreement is
reached.
If the Reporting Persons reach an agreement with funding, sources and with the Issuer, it is expected that the contemplated
transaction will be subject to (i) shareholder approval, (ii) potentially the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and
(iii) satisfaction of all consents, approvals or authorizations of, declarations or filings under applicable all applicable laws (domestic and foreign), including competition laws and investment laws.